IRON Latest Press Releases

-- June 22, 2026 --

ROSEN, LEADING INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 4:44 PM

-- June 20, 2026 --

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 2:13 PM

-- June 16, 2026 --

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 11:09 AM

-- June 15, 2026 --

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights Globe Newswire 7:25 PM

-- June 13, 2026 --

ROSEN, LEADING INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 10:13 AM

-- June 12, 2026 --

Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting Globe Newswire 8:30 AM

-- June 10, 2026 --

ROSEN, A LONGSTANDING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 10:08 PM

-- June 9, 2026 --

Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria Globe Newswire 8:30 AM

-- June 5, 2026 --

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 5:20 PM

-- June 2, 2026 --

IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights Globe Newswire 4:50 PM

Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Globe Newswire 8:00 AM

-- June 1, 2026 --

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 9:35 PM

Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients Globe Newswire 8:30 AM

-- May 31, 2026 --

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 9:30 PM

-- May 29, 2026 --

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 11:18 PM

-- May 28, 2026 --

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON PRNewswire 5:56 PM

-- May 24, 2026 --

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 8:11 PM

-- May 12, 2026 --

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 2:16 PM

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress Globe Newswire 9:30 AM

-- May 11, 2026 --

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON PRNewswire 10:10 PM

Disc Medicine to Participate in Upcoming Investor Conferences Globe Newswire 8:30 AM

-- May 5, 2026 --

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 5:26 PM

Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 8:30 AM

-- May 3, 2026 --

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 9:27 PM

-- April 30, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON PRNewswire 10:40 PM

-- April 29, 2026 --

ROSEN, LEADING INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 5:32 PM

-- April 28, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON Globe Newswire 10:17 PM

-- April 27, 2026 --

ROSEN, A LONGSTANDING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 7:54 PM

-- April 26, 2026 --

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 7:49 PM

-- April 25, 2026 --

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON PRNewswire 3:58 AM

-- April 21, 2026 --

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 10:33 PM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON Globe Newswire 5:09 PM

Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting Globe Newswire 10:00 AM

-- April 20, 2026 --

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 10:27 PM

-- April 16, 2026 --

IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates Globe Newswire 9:00 AM

-- April 15, 2026 --

IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights Globe Newswire 5:25 PM

-- April 14, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON Globe Newswire 5:08 PM

-- April 10, 2026 --

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 10:36 PM

-- April 9, 2026 --

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON PRNewswire 5:36 PM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON PRNewswire 10:01 AM

-- April 3, 2026 --

ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Globe Newswire 10:01 PM

ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Globe Newswire 10:00 PM

-- April 2, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON PRNewswire 10:00 AM

-- March 31, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON Globe Newswire 6:18 PM

-- March 30, 2026 --

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON PRNewswire 5:41 PM

-- March 29, 2026 --

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 10:58 PM

-- March 28, 2026 --

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 10:57 PM

-- March 27, 2026 --

Disc Medicine, Inc. Investigated by the Portnoy Law Firm Globe Newswire 9:00 AM

-- March 26, 2026 --

Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria Globe Newswire 4:30 PM

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 1:57 PM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON PRNewswire 10:00 AM

-- March 25, 2026 --

IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine PRNewswire 9:01 AM

-- March 24, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. - IRON Globe Newswire 5:51 PM

-- March 23, 2026 --

ROSEN, A LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 3:52 PM

-- March 22, 2026 --

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Newsfile 9:15 AM

-- March 21, 2026 --

IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights Globe Newswire 10:23 AM

-- March 20, 2026 --

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON PRNewswire 4:10 PM

-- March 19, 2026 --

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON Business Wire 12:56 PM

-- March 18, 2026 --

IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm Globe Newswire 10:20 AM

IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates PRNewswire 9:01 AM

-- March 14, 2026 --

IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm Business Wire 5:39 PM

-- March 12, 2026 --

IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates Globe Newswire 9:00 AM

-- March 11, 2026 --

IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine PRNewswire 9:01 AM

-- March 3, 2026 --

Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight PRNewswire 5:31 PM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON Globe Newswire 3:37 PM

-- February 26, 2026 --

Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Globe Newswire 8:30 AM

-- February 24, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON Globe Newswire 5:23 PM

-- February 19, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON PRNewswire 8:06 PM

-- February 17, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON Globe Newswire 4:58 PM

-- February 13, 2026 --

Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP Globe Newswire 3:04 PM

-- February 12, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON PRNewswire 6:51 PM

-- February 3, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON Globe Newswire 1:10 PM

-- January 29, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON PRNewswire 10:00 AM

-- January 27, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. - IRON Globe Newswire 12:33 PM